Related Experiment Videos
[Comparison of the different methods to calculate cerebral glucose utilization using F-18 FDG and PET]
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|March 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression.
ESMO real world data and digital oncology·2026
Functional analysis of thermo-sensitive TRPV1 in an aquatic vertebrate, masu salmon (Oncorhynchus masou ishikawae).
Biochemistry and biophysics reports·2022
[Prevention of Radiation Detection Issues at International Airports Following Nuclear Medicine Procedures: The Role of Pre-travel Screening].
Kaku igaku. The Japanese journal of nuclear medicine·2026
[Prognostic Value of Myocardial Flow Reserve Derived from 13N-ammonia PET in Patients with Ischemic Heart Disease in Japan].
Kaku igaku. The Japanese journal of nuclear medicine·2026
[The 47th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 50th Survey in 2024)].
Kaku igaku. The Japanese journal of nuclear medicine·2026
[A Report on Health Resource Use in Internal Radiation Therapy Using Lutetium-177 (177Lu)-PSMA-617].
Kaku igaku. The Japanese journal of nuclear medicine·2025
[Evaluation of Appropriate Treatment Infrastructure for Radionuclide Therapy Through Discrete Event Simulation].
Kaku igaku. The Japanese journal of nuclear medicine·2025
Did You Know That Confounding Could Bias Results Obtained within an Economic Evaluation?
Medical decision making : an international journal of the Society for Medical Decision Making·2026
Costs of surgeries in low- and middle-income countries: a systematic literature review.
BMJ global health·2026
Evaluating technology upgrades as a complement to traditional bill assistance programs.
Nature communications·2026